Wedbush Securities’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-834
| Closed | -$275K | – | 1257 |
|
|
2024
Q2 | $275K | Sell |
834
-1,182
| -59% | -$390K | 0.01% | 904 |
|
|
2024
Q1 | $798K | Buy |
2,016
+680
| +51% | +$269K | 0.03% | 468 |
|
|
2023
Q4 | $470K | Sell |
1,336
-17
| -1% | -$5.98K | 0.02% | 574 |
|
|
2023
Q3 | $508K | Sell |
1,353
-18
| -1% | -$6.76K | 0.03% | 516 |
|
|
2023
Q2 | $524K | Buy |
1,371
+5
| +0.4% | +$1.91K | 0.03% | 525 |
|
|
2023
Q1 | $473K | Hold |
1,366
| – | – | 0.02% | 557 |
|
|
2022
Q4 | $321K | Sell |
1,366
-75
| -5% | -$17.6K | 0.02% | 709 |
|
|
2022
Q3 | $355K | Sell |
1,441
-106
| -7% | -$26.1K | 0.02% | 651 |
|
|
2022
Q2 | $468K | Sell |
1,547
-45
| -3% | -$13.6K | 0.03% | 552 |
|
|
2022
Q1 | $654K | Sell |
1,592
-20
| -1% | -$8.22K | 0.03% | 479 |
|
|
2021
Q4 | $756K | Sell |
1,612
-10
| -0.6% | -$4.69K | 0.03% | 464 |
|
|
2021
Q3 | $689K | Sell |
1,622
-75
| -4% | -$31.9K | 0.03% | 471 |
|
|
2021
Q2 | $609K | Buy |
1,697
+102
| +6% | +$36.6K | 0.03% | 552 |
|
|
2021
Q1 | $449K | Buy |
1,595
+104
| +7% | +$29.3K | 0.02% | 622 |
|
|
2020
Q4 | $422K | Buy |
1,491
+280
| +23% | +$79.2K | 0.04% | 525 |
|
|
2020
Q3 | $333K | Sell |
1,211
-236
| -16% | -$64.9K | 0.03% | 566 |
|
|
2020
Q2 | $329K | Sell |
1,447
-34
| -2% | -$7.73K | 0.03% | 573 |
|
|
2020
Q1 | $225K | Buy |
1,481
+121
| +9% | +$18.4K | 0.03% | 635 |
|
|
2019
Q4 | $204K | Buy |
+1,360
| New | +$204K | 0.02% | 858 |
|